The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.
Patients diagnosed with COVID-19 infection and admitted to the ICU were recruited. Demographic information, comorbidities, length of ICU stay, some laboratory data,thromboembolic complications of the patients were recorded.
Study Type
OBSERVATIONAL
Enrollment
484
Derince Research and Training Hospital
Kocaeli, Derince, Turkey (Türkiye)
Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease
Both arterial and venous thromboembolic events were detected
Time frame: During the entire intensive care stay up to 1 day
Rate of thromboembolic complications of COVID-19 disease in critically ill patients
Both arterial and venous thromboembolic events were detected
Time frame: During the entire intensive care stay up to 1 day
Rate of thromboembolic complications according to anticoagulant therapy
Antithrombotic therapy of each patient was recorded
Time frame: During the entire intensive care stay up to 1 day
What is the rate of thromboembolism according to the comorbidities
Comorbidities of each patient were recorded from the patients records.
Time frame: During the entire intensive care stay up to 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.